Skip to main content

Table 6 Outcome Data

From: The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery

  MB Group
n = 311
Non-MB Group
n = 202
p-value
30-Day Mortality 57 [18] 10 [5] 0.001
Stay
ICU [d] 26 ± 29 16 ± 16 0.001
IMC [d] 15 ± 18 6 ± 8 0.001
GW [d] 6 ± 19 4 ± 7 n.s.
Renal Failure 130 [42] 30 [15] 0.001
Renal Replacement Therapy 149 [48] 34 [17] 0.001
Respiratory Failure 81 [27] 6 [3] 0.001
Liver Failure 22 [7] 4 [2] 0.007
First Defecation [d] 3.6 ± 2.2 2.3 ± 1.8 0.001
Cerebrovascular Events 44 [15] 10 [5] 0.001
Multi-Organ Failure 40 [13] 8 [4] 0.001
Sepsis 26 [9] 9 [45] n.s.
TISS10 172 163  
 ADM 23.2 ± 8.7 20.1 ± 6.9 0.001
 MAXIMUM 30.2 ± 6.8 24.2 ± 6.6 0.001
SAPSII 140 163  
 ADM 24.19 ± 13.62 21.91 ± 12.13 n.s.
 MAXIMUM 35.52 ± 17.85 46.18 ± 252.34 n.s.
Ventilation Time [h] 246 ± 900 60 ± 101 0.001
Vasopressor-Free Days in ICU [d] 12.3 ± 26.8 11.0 ± 12.4 n.s.
  1. ICU Intensive care unit, IMC Intermediate care unit, GW General ward, TISS Therapeutic intervention scoring system, SAPSII Simplified acute physiology score. All data are presented as number [%] or mean +/− SD. n.s.: not significant